After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Kronos Bio Inc is $53.17M. A total of 1.78 million shares were traded on the day, compared to an average of 718.06K shares.
In the most recent transaction, KNOBELMAN DEBORAH sold 24,838 shares of KRON for 0.87 per share on Jun 05 ’25. After the transaction, the President & Interim CEO now owns 139,422 company shares. In a previous transaction on Jun 27 ’24, BISCHOFBERGER NORBERT W bought 410,848 shares at 1.17 per share. KRON shares that PRESIDENT & CEO owns now total 10,597,468.
Among the insiders who bought shares, BISCHOFBERGER NORBERT W acquired of 204,670 shares on Jun 28 ’24 at a per-share price of $1.25. This resulted in the PRESIDENT & CEO holding 10,802,138 shares of KRON after the transaction. In another insider transaction, BISCHOFBERGER NORBERT W bought 1,378,901 shares at $0.88 per share on Jun 10 ’24. Company shares held by the PRESIDENT & CEO now total 5,749,395.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, KRON has a high of $1.60 and a low of $0.65.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. KRON’s latest balance sheet shows that the firm has $339.51M in Cash & Short Term Investments as of fiscal 2021. There were $33.76M in debt and $13.63M in liabilities at the time. Its Book Value Per Share was $1.31, while its Total Shareholder’s Equity was $345.10M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KRON is Buy with a score of 5.00.
